TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Tvingsholm SA, et al.
Journal for ImmunoTherapy of Cancer
August 2023
Authors and Affiliates
Siri Amanda Tvingsholm 1, Marcus Svensson Frej 2, Vibeke Mindahl Rafa 1, Ulla Kring Hansen 2, Maria Ormhøj 1, Alexander Tyron 1, Agnete W P Jensen 3, Mohammad Kadivar 1, Amalie Kai Bentzen 1, Kamilla K Munk 1, Gitte N Aasbjerg 1, Jeppe S H Ternander 2, Christina Heeke 1, Tripti Tamhane 1, Christian Schmess 4, Samuel A Funt 5, Julie Westerlin Kjeldsen 3, Anders Handrup Kverneland 3, Özcan Met 6, Arianna Draghi 3, Søren Nyboe Jakobsen 1, Marco Donia 3, Inge Marie Svane 3, Sine Reker Hadrup 7;
1 Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
2 PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark.
3 National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark.
4 NMI Natural and Medical Science Institute, University of Tübingen, Tubingen, Germany.
5 Deptartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
6 National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Copenhagen, Denmark.
7 Department of Health Technology, Technical University of Denmark, Lyngby, Denmark sirha@dtu.dk.